Skip to content

Clinical trials

Completed Lymphoma, Large B-Cell, Diffuse trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Completed Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20133
20151
20161
20171
20192
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Novartis Pharmaceuticals2
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Celgene1
Epizyme, Inc.1
Incyte Corporation1
Janssen Research & Development, LLC1
MorphoSys AG1
National Health Research Institutes, Taiwan1
National Taiwan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Lymphoma2
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.